The future of biotech is founder-led | Tony Kulesa | Pillar VC

Ideas, technology, and investment capital are no longer the scarcest resources; the limiting reagent is founders. We can change that.

The future of biotech is founder-led | Tony Kulesa | Pillar VC Skip to content The future of biotech is founder-led Tony Kulesa Posted: August 18, 2021 Over the last decade, there has been an incredible surge in technologies and discoveries in the life sciences, enabling a new generation of companies to grow faster and larger than ever before. Investors are responding, and a record amount of capital is now available to biotech startups. Yet, company creation has lagged. Ideas, technology, and investment capital are no longer the scarcest resources; the limiting reagent is founders. We can chan

related reading

• Biotech Startups: Move Slow and Fix Things - Stanford Biotechnology Groupstanfordbiotechgroup.com
• Tech vs Biotech - Celine Haliouacelinehh.com
• Fundraising for Founder-led Biotech – Matt Krisiloffmattkrisiloff.com
• “Build What’s Fundable” - by Kyle Harrison - Investing 101investing101.substack.com
• How to start a biotech company, in the words of the founding CEO of Genentechbaybridgebio.com
• Rebuild Biotech for the AI Era | Benchlingbenchling.com
• Early-Stage Biotech Value Creation: The Roles of Equity and Partnershipsleadershipandbiotechnology.blogspot.com
• Where are all the trillion dollar biotechs?ladanuzhna.xyz
• List of biotech founders and drug hunters who were unlikely to succeed (and yet they did)ladanuzhna.xyz
• The Biotech Delusion: Things No One Wants to Admitmattshlosberg.substack.com
• Biotech’s Dulcius Ex Asperis: The Way Through This Downturn - RApportrapport.bio
• Gene Pool Engineering for Entrepreneurskhoslaventures.com